358 related articles for article (PubMed ID: 18718015)
1. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
2. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
3. Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Ann N Y Acad Sci; 2005 May; 1041():462-9. PubMed ID: 15956747
[TBL] [Abstract][Full Text] [Related]
4. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
[TBL] [Abstract][Full Text] [Related]
5. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
6. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
8. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and TCDD influence RLN2 gene activity in estrogen receptor-positive human breast cancer cells.
Kietz S; Feng S; Agoulnik A; Hombach-Klonisch S
Ann N Y Acad Sci; 2009 Apr; 1160():367-73. PubMed ID: 19416221
[TBL] [Abstract][Full Text] [Related]
10. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
[TBL] [Abstract][Full Text] [Related]
11. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
[TBL] [Abstract][Full Text] [Related]
12. Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.
Bialek J; Kunanuvat U; Hombach-Klonisch S; Spens A; Stetefeld J; Sunley K; Lippert D; Wilkins JA; Hoang-Vu C; Klonisch T
Mol Cancer Res; 2011 Jun; 9(6):673-87. PubMed ID: 21493587
[TBL] [Abstract][Full Text] [Related]
13. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
14. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
[TBL] [Abstract][Full Text] [Related]
15. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
16. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
17. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
[TBL] [Abstract][Full Text] [Related]
19. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
20. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
